(MRC Working party on Leukaemia in Adults) Chronic Lymphocytic Leukaemia trial 4: A Randomised Comparison of Chlorambucil, Fludarabine and Fludarabine plus Cyclophosphamide

Trial Profile

(MRC Working party on Leukaemia in Adults) Chronic Lymphocytic Leukaemia trial 4: A Randomised Comparison of Chlorambucil, Fludarabine and Fludarabine plus Cyclophosphamide

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jan 2016

At a glance

  • Drugs Fludarabine (Primary) ; Fludarabine (Primary) ; Chlorambucil; Cyclophosphamide; Cyclophosphamide
  • Indications Chronic lymphocytic leukaemia
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 08 Dec 2015 Accrual to date is 106%, according to United Kingdom Clinical Research Network record.
    • 01 Jul 2012 Results published in Leukemia and Lymphoma.
    • 27 Mar 2012 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top